These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 765146)

  • 21. [Physicochemical aspects of the liberation of water-soluble preparations from hydrophobic ointment bases].
    Muravĭov IO; Kononikhina NF
    Farm Zh; 1980; (2):57-60. PubMed ID: 7389881
    [No Abstract]   [Full Text] [Related]  

  • 22. Kinetics and mechanisms in stability of drugs.
    Garrett ER
    Adv Pharm Sci; 1967; 2():1-94. PubMed ID: 4862946
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative effectiveness of conservants of drug suspensions for peroral use].
    Belozerova OP; Efimova TI
    Farmatsiia; 1969; 18(6):28-31. PubMed ID: 5379667
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effectivness prolongation of drugs with special consideration for peroral depot drug forms].
    Hänselmann B; Voigt R
    Pharmazie; 1971 Feb; 26(2):57-77. PubMed ID: 4930108
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the disintegration and stabilization of sulfacetamide-sodium and pharmaceutical preparations].
    Pandula E; Rácz I; Pajor Z
    Pharmazie; 1969 Mar; 24(3):155-7. PubMed ID: 5787491
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lacquered tablets and film dragees].
    Hess H; Janssen HJ
    Pharm Acta Helv; 1969 Oct; 44(10):581-601. PubMed ID: 4901296
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of formulation on drug action.
    Münzel K
    Pharm Acta Helv; 1971 Sep; 46(9):513-38. PubMed ID: 5099398
    [No Abstract]   [Full Text] [Related]  

  • 28. [Gelatin capsules].
    Griadunova GP; Litvinova TP; Davigora IV
    Farmatsiia; 1975; 24(4):72-7. PubMed ID: 767147
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of a comparative analysis of sedimentation and Brownian motion as a guide to suspension formulation.
    Matthews BA; Rhodes CT
    Pharm Acta Helv; 1970 Jan; 45(1):52-9. PubMed ID: 5436734
    [No Abstract]   [Full Text] [Related]  

  • 30. Rectal administration of drugs.
    Senior N
    Adv Pharm Sci; 1974; 4():363-435. PubMed ID: 4618035
    [No Abstract]   [Full Text] [Related]  

  • 31. [Production and study of sulfadimethoxine suspensions with various stabilizers].
    Kuprina NA; Blagovidova IuA; Knizhnik AZ
    Farmatsiia; 1975; 24(2):27-30. PubMed ID: 1175803
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of nipagin in a preparation and in drug forms].
    Liubarskaia AG; Eĭlazian OG
    Farm Zh; 1974; 29(5):53-6. PubMed ID: 4463087
    [No Abstract]   [Full Text] [Related]  

  • 33. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Injection casting procedure for the preparation of oral delayed-action preparations. 4. Break-in of channeling pharmaceutic aids].
    Hüttenrauch R; Schmeiss U
    Pharmazie; 1976 Jul; 31(7):471-4. PubMed ID: 981302
    [No Abstract]   [Full Text] [Related]  

  • 35. [Alginic acid in pharmacy and medicine].
    Iasnitskiĭ BG; Bezuglaia LP; Dol'berg EB
    Farmatsiia; 1979; 28(6):58-62. PubMed ID: 391598
    [No Abstract]   [Full Text] [Related]  

  • 36. [Manufacturing and properties of pharmaceutical spray dry products].
    Nürnberg E
    Acta Pharm Hung; 1978 Jan; 48(1):19-35. PubMed ID: 636895
    [No Abstract]   [Full Text] [Related]  

  • 37. [Stability and stabilization of drugs. V. Drug forms].
    Speiser P
    Pharm Acta Helv; 1968; 43(2):65-78. PubMed ID: 5720916
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of a fatty acid ester (Precirol) in drug technology].
    Stampf G; Karoliny V
    Acta Pharm Hung; 1974 Nov; 44(6):283-8. PubMed ID: 4428975
    [No Abstract]   [Full Text] [Related]  

  • 39. Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions.
    Kanaze FI; Kokkalou E; Niopas I; Barmpalexis P; Georgarakis E; Bikiaris D
    Drug Dev Ind Pharm; 2010 Mar; 36(3):292-301. PubMed ID: 19663560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On the use of the dispersing agent Elmix 3 in producing pharmaceutical suspensions].
    Brezhneva NM; Kuprina NA
    Aptechn Delo; 1966; 15(4):19-23. PubMed ID: 5990576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.